WuXi Apptec will sell its Advanced Technologies unit to the US private equity firm Altaris for an undisclosed amount, a ...

The Federal Trade Commission is praising an appeals court decision calling for Teva to delist five inhaler patents from the ...

Novo Nordisk's CagriSema fell short of weight loss goals, causing 17% stock drop. Drug shows similar results to Eli Lilly's ...

Amgen, Eli Lilly and UCB sued the federal government, claiming that several STD clinics getting drug discounts under the ...

Generic drug firm Viatris announced Monday that one of its India-based manufacturing facilities has been placed on import ...

The FDA on Friday issued two simultaneous cystic fibrosis approvals for Vertex Pharmaceuticals, but included boxed safety ...

Eli Lilly dominates obesity market, megadeals decline, I&I sector thrives, and FDA's setback in misinformation fight.

FDA approves Novo Nordisk's Alhemo for hemophilia A and B with inhibitors. Once-daily shot reduces bleeding episodes in ...

Sumitomo Pharma’s oral treatment for overactive bladder symptoms has won an expanded label from the FDA, and is now approved ...

Bristol Myers Squibb's Sotyktu succeeds in Phase 3 psoriatic arthritis trials, as company leads TYK2 race against Takeda & ...

House Speaker Johnson and GOP push for narrow spending bill without healthcare reforms as midnight shutdown deadline looms; ...

Bris­tol My­ers Squibb is part­ner­ing with the orig­i­nal de­vel­op­er of Leqem­bi in a new Alzheimer’s dis­ease deal. Get ...